Announced Sat, 4 Jul · 18:05 IST
Sarda Proteins: Major board reshuffle, authorised capital raised to 100 Crore
Corporate Actions View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
Sarda Proteins board approved increasing authorised equity share capital from 13 Crore to 100 Crore rupees (1.30 Crore to 10 Crore shares of 10 rupees each). Chirag Thumar resigned as MD; Shirish Savaliya appointed new MD for 5 years. Yagnik Satasia moved from CFO to Non-Executive Chairperson. Drashti Delvadiya appointed new CFO. Three directors resigned. Object clause of MOA to be altered. EGM to be convened.
Likely market impact
Major leadership reshuffle with new MD and CFO. Authorised capital hike to 100 Crore hints at possible fundraising or expansion. Subject to shareholder nod.